Activation of NLRP3 in the placenta, uterus, kidneys, and maternal endothelium leads to the production of pro-inflammatory cytokines (IL-1β and IL-18) and triggers processes such as endothelial dysfunction, sodium retention, and hypertension. This evidence concerns the gene NLRP3 and endothelial dysfunction.